首页 > 期刊杂志 > 正文

The role of SOX11 immunostaining in confirming the diagnosis of mantle cell lymphoma on fine-needle aspiration samples.

SOX11免疫组化染色在细针穿刺标本确诊套细胞淋巴瘤中的作用

Zhang YH,Liu J,Dawlett M,Guo M,Sun X,Gong Y

Abstract

Mantle cell lymphoma (MCL) demonstrates cytologic features that overlap with those of other types of B-cell non-Hodgkin lymphomas (B-cell NHLs) containing small to medium-sized cells. The accurate diagnosis of MCL is important because MCL has relatively more aggressive biologic behavior and thus requires specific treatment regimens. Fine-needle aspiration (FNA) is used for diagnosing or staging lymphoma, often with the help of immunophenotyping by flow cytometry. However, the cellularity of an FNA sample may not be high enough for flow cytometry, leading to diagnostic difficulty. SOX11 immunostaining is helpful in the diagnosis of MCL in histologic sections. However, to the authors' knowledge, its diagnostic value for FNA samples has not been studied to date.
Immunostains for SOX11 were performed on 69 FNA cases with final diagnoses of MCL (13 cases, including 10 classic type and 3 blastoid variant), marginal zone lymphoma (8 cases), follicular lymphoma (10 cases), small lymphocytic lymphoma (12 cases), Burkitt lymphoma (9 cases), plasma cell myeloma (7 cases), and benign lymph nodes (10 cases). Preparation types included cytospin slides (65 cases), direct smears (2 cases), and cell block sections (2 cases). The percentage of positive cells (defined as nuclear staining) and staining intensity were recorded.
All 13 cases of MCL were positive for SOX11 staining, with 12 cases demonstrating diffuse positivity. All other types of B-cell NHL cases, plasma cell myelomas, and benign lymph nodes were found to have negative results. Weak staining was found in 1 MCL case of blastoid variant.
SOX11 immunostaining on FNA samples is highly sensitive and specific for MCL and can be used as a reliable adjunct to confirm MCL, especially in a recurrent setting.

摘要

套细胞淋巴瘤(MCL)与其他包含小-中等大小细胞的B细胞非霍奇金淋巴瘤(B-cell NHLs)在细胞学特点上有重叠。由于套细胞淋巴瘤生物学行为相对更具有侵袭性并需要特定方案治疗,因此准确诊断套细胞淋巴瘤是很重要的。细针穿刺(FNA),通常辅以流式细胞术分析免疫表型,可以用于淋巴瘤的诊断和分期。但细针穿刺标本的细胞量可能不足以进行流式细胞分析,这导致诊断困难。SOX11免疫组化染色对组织切片中套细胞淋巴瘤的诊断有帮助。但就作者所知,它在细针穿刺标本中的诊断价值尚未有研究。

69例细针穿刺病例行SOX11免疫组化染色,这些病例最终诊断包括套细胞淋巴瘤(13例,包括10例经典型和3例母细胞型)、边缘区淋巴瘤(8例)、滤泡性淋巴瘤(10例)、小淋巴细胞型淋巴瘤(12例)、伯基特淋巴瘤(9例)、浆细胞骨髓瘤(7例)和良性病变淋巴结(12例)。细胞制片类型包括细胞离心片(65例)、直接涂片(2例)和细胞块切片(2例)。记录阳性细胞百分比(定义为核染色)和染色强度。

所有13例MCL均SOX11染色阳性,其中12例显示为弥漫阳性。其他类型的B细胞非霍奇金淋巴瘤、浆细胞骨髓瘤和良性病变淋巴结均为阴性。1例母细胞型MCL显示弱阳性。

FNA标本SOX11免疫组化染色对MCL高度敏感和特异,是一种可靠的确诊MCL辅助方法,当肿瘤复发时尤其有用。

full text

我要评论

0条评论